Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@GolfNut48846224 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1249712127646093313.png) @GolfNut48846224 Golf 🔩

Golf 🔩 posts on X about $uthr, $lqda, $prtc, $bmy the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

### Engagements: X [#](/creator/twitter::1249712127646093313/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1249712127646093313/c:line/m:interactions.svg)

- X Week XX -XX%
- X Month XXXXX -XXXX%
- X Months XXXXXX +60%
- X Year XXXXXX -XX%

### Mentions: X [#](/creator/twitter::1249712127646093313/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1249712127646093313/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XX +26%
- X Year XXX +43%

### Followers: XXX [#](/creator/twitter::1249712127646093313/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1249712127646093313/c:line/m:followers.svg)

- X Week XXX -XXXX%
- X Month XXX -XXXX%
- X Months XXX +7%
- X Year XXX -XX%

### CreatorRank: undefined [#](/creator/twitter::1249712127646093313/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1249712127646093313/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1249712127646093313/influence)
---

**Social category influence**
[stocks](/list/stocks)  XX%

**Social topic influence**
[$uthr](/topic/$uthr) #22, [$lqda](/topic/$lqda) #33, [$prtc](/topic/$prtc) 25%, [$bmy](/topic/$bmy) 25%, [$5billion](/topic/$5billion) 25%, [$83b](/topic/$83b) 25%, [market cap](/topic/market-cap) 25%, [$4b](/topic/$4b) XX%

**Top accounts mentioned or mentioned by**
[@josh44282819](/creator/undefined) [@amheshay](/creator/undefined) [@aimhardy](/creator/undefined) [@sajyboy](/creator/undefined) [@scartissue123](/creator/undefined)

**Top assets mentioned**
[United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy)
### Top Social Posts [#](/creator/twitter::1249712127646093313/posts)
---
Top posts by engagements in the last XX hours

"@Josh44282819 The drug just works. We continue to see evidence that LYT100 doesnt just slow IPF it stabilises lung function decline to match those without the disease $PRTC $LQDA $UTHR $BMY"  
[X Link](https://x.com/GolfNut48846224/status/1972606560410165362) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-29T10:17Z XXX followers, 1360 engagements


"@AmheShay @Josh44282819 Correct. Antifibrotics like pirfenidone and nintedanib will remain standard treatments for idiopathic pulmonary fibrosis (IPF). I suspect Tyvaso will predominantly be used as an add-on therapy. Tyvaso's efficacy was highest when combined with nintedanib. $LQDA $UTHR"  
[X Link](https://x.com/GolfNut48846224/status/1972635720767648107) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-29T12:13Z XXX followers, 1214 engagements


"@AimHardy If these results replicate in a p3 trial & deuprifenidone gets FDA approval we are looking at a drug worth $5billion. Roche paid $8.3B in 2014 for Esbriet (Pirfenidone). $UTHR market cap surged by $4B in a single day driven by positive p3 data for Tyvaso in treating IPF"  
[X Link](https://x.com/GolfNut48846224/status/1972948354314465434) [@GolfNut48846224](/creator/x/GolfNut48846224) 2025-09-30T08:55Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@GolfNut48846224 Avatar @GolfNut48846224 Golf 🔩

Golf 🔩 posts on X about $uthr, $lqda, $prtc, $bmy the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

Engagements Line Chart

  • X Week XX -XX%
  • X Month XXXXX -XXXX%
  • X Months XXXXXX +60%
  • X Year XXXXXX -XX%

Mentions: X #

Mentions Line Chart

  • X Week X -XX%
  • X Month XX -XX%
  • X Months XX +26%
  • X Year XXX +43%

Followers: XXX #

Followers Line Chart

  • X Week XXX -XXXX%
  • X Month XXX -XXXX%
  • X Months XXX +7%
  • X Year XXX -XX%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XX%

Social topic influence $uthr #22, $lqda #33, $prtc 25%, $bmy 25%, $5billion 25%, $83b 25%, market cap 25%, $4b XX%

Top accounts mentioned or mentioned by @josh44282819 @amheshay @aimhardy @sajyboy @scartissue123

Top assets mentioned United Therapeutics, Corp. (UTHR) Bristol-Myers Squibb Co (BMY)

Top Social Posts #


Top posts by engagements in the last XX hours

"@Josh44282819 The drug just works. We continue to see evidence that LYT100 doesnt just slow IPF it stabilises lung function decline to match those without the disease $PRTC $LQDA $UTHR $BMY"
X Link @GolfNut48846224 2025-09-29T10:17Z XXX followers, 1360 engagements

"@AmheShay @Josh44282819 Correct. Antifibrotics like pirfenidone and nintedanib will remain standard treatments for idiopathic pulmonary fibrosis (IPF). I suspect Tyvaso will predominantly be used as an add-on therapy. Tyvaso's efficacy was highest when combined with nintedanib. $LQDA $UTHR"
X Link @GolfNut48846224 2025-09-29T12:13Z XXX followers, 1214 engagements

"@AimHardy If these results replicate in a p3 trial & deuprifenidone gets FDA approval we are looking at a drug worth $5billion. Roche paid $8.3B in 2014 for Esbriet (Pirfenidone). $UTHR market cap surged by $4B in a single day driven by positive p3 data for Tyvaso in treating IPF"
X Link @GolfNut48846224 2025-09-30T08:55Z XXX followers, XXX engagements

@GolfNut48846224
/creator/twitter::GolfNut48846224